Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 19,788 results that match your search.19,788 results
  • The EU Biotechnology Directive (98/44/EC) was controversial in the making and remains so. The member states of the EU had until July 31 2000 to transpose the Biotechnology Directive into their national legal systems. So far only five of them have done so.
  • We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
  • Guidance on protecting colour combinations in Europe has evolved over time. But in the light of recent decisions is further clarification needed? Roland Mallinson investigates
  • After seven years of debate, and 19 formal rounds of negotiations, the Trans-Pacific Partnership was agreed in October this year. Its IP provisions, which are among the most controversial, will have an impact on pharmaceutical protection, copyright, trade marks, geographical indications and enforcement, among other areas. Peter Leung provides a summary of the main points and over the following pages we look at the impact country-by-country
  • Conrad Wong is the IP rights officer at the US Consulate General in Guangzhou. Before he leaves in September after a five-year stint in the role he spoke to Managing IP about what foreign businesses in China can do to maximise their rights
  • New Zealand's new Patents Act 2013 will come into force on or before September 13 2014. The main changes include tougher examination of patent applications, timing and deadlines, subject matter exclusions and divisional applications.
  • Luiz Otávio Pimentel knew he had a tough job facing him when he took over as President of Brazil’s National Institute of Industrial Property, Ministry of Development and Foreign Trade (INPI) in July. That job became even harder as a result of Brazil revealing it entered recession in the second quarter. With that, comes a hiring freeze handed to the office by the government. The new man at Brazil’s patent and trade mark office needs to get creative
  • As a party to the United States-Mexico-Canada Agreement (USMCA), Canada has agreed to adopt important new protections for biologic and other pharmaceutical innovation, as well as other changes to strengthen its patent system and harmonise certain IP laws with its trading partners.
  • The Federal Circuit has ordered the Eastern District of Texas to grant a stay in Rockstar’s dispute with Google over the Android operating system pending the outcome of an action in the Northern District of California, saying that denying a stay was “a clear abuse of discretion”
  • When an EU trade mark (EUTM, formerly known as CTM) is registered its owner has five years to use it in a sufficiently broad way within the European Union. If he does not exceed his mere local use of his EUTM within this time slot, his EUTM is not only open to cancellation but he can also not derive rights from it to forbid others to use this mark and similar marks. This is what teaches us the following case.